The nature of the surface is critical in determining the biological activity of silica powders. A novel correlation between toxicity and surface properties of bioactive glass ceramics (BGCs) synthesized via the sol–gel method was attempted in this study.
The behavior of BGCs after their attachment to the surface of red blood cells (RBCs) was evaluated and their toxic effects were determined based on hemolysis, membrane injury via anti-phosphotyrosine immunoblot of Band 3, lipid peroxidation, potential to generate reactive oxygen species, and antioxidant enzyme production. In particular, three BGCs were synthesized and treated at three sintering temperatures (T1 = 835 °C, T2 = 1000 °C and T3 = 1100 °C) to investigate possible relation between surface charge or structure and hemolytic potential.
Their toxicity based on hemolysis was dose dependent, while BGC-T2 had the best hemocompatibility in compare with the other BGCs.No BGCs in dosages lower than 0.125 mg/mL could damage erythrocytes. On the other hand, all BGCs promoted the production of reactive oxygen species in certain concentrations, with the BGC-T2 producing the lowest ROS and increasing the glutathione levels in RBCs protecting their damage.
The results suggest that various factors such as size, a probable different proportion of surface silanols, a balanced mechanism between calcium and magnesium cellular uptake or the different crystalline nature may have contributed to this finding; however, future research is needed to clarify the underlying mechanisms.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Andre, N., et al. Toxic potential of materials at the nanolevel. Science 80(311):622–627, 2006.
Aseichev, A. V., et al. Effects of gold nanoparticles on erythrocyte hemolysis. Bull. Exp. Biol. Med. 156:495–498, 2014.
Bakshi, M. S. Nanotoxicity in systemic circulation and wound healing. Chem. Res. Toxicol. 2017. https://doi.org/10.1021/acs.chemrestox.7b00068.
Balani, K., et al. Biosurfaces: a materials science and engineering perspective. Biosurfaces 2015. https://doi.org/10.1002/9781118950623.
Banerjee, R., K. Nageswari, and R. R. Puniyani. Hematological aspects of biocompatibility: review article. J. Biomater. Appl. 1997. https://doi.org/10.1177/088532829701200104.
Barrère, F., et al. Advanced biomaterials for skeletal tissue regeneration: instructive and smart functions. Mater. Sci. Eng. R 2008. https://doi.org/10.1016/j.mser.2007.12.001.
Bian, Y., K. Kim, T. Ngo, I. Kim, O. N. Bae, K. M. Lim, and J. H. Chung. Silver nanoparticles promote procoagulant activity of red blood cells: a potential risk of thrombosis in susceptible population. Part Fibre Toxicol. 16(1):9, 2019. https://doi.org/10.1186/s12989-019-0292-6.
Bogdanova, A., et al. Calcium in red blood cells: a perilous balance. Int. J. Mol. Sci. 5:9848–9872, 2013.
Brückner, R. Properties and structure of vitreous silica. I. J. Non. Cryst. Solids 5:123–175, 1970.
Cash, T. P., Y. Pan, and M. C. Simon. Reactive oxygen species and cellular oxygen sensing. Free Radic. Biol. Med. 43:1219, 2007.
Chang, J. S., et al. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ. Sci. Technol. 41:2064–2068, 2007.
Corba, C., et al. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine 11:81–100, 2016.
Day, S. J., et al. Thermal processing and crystallization of amorphous Mg–Ca silicates. Meteorit. Planet. Sci. 48:1459–1471, 2013.
Dayem, A. A., et al. The role of reactive oxygen species (ROS) in the biological activities of metallic nanoparticles. Int. J. Mol. Sci. 18:48–52, 2017.
De Mel, A., B. G. Cousins, and A. M. Seifalian. Surface modification of biomaterials: a quest for blood compatibility. Int. J. Biomater. 2012. https://doi.org/10.1155/2012/707863.
Degli Esposti, L., et al. Calcium phosphate-based nanosystems for advanced targeted nanomedicine. Drug Dev. Ind. Pharm. 44:1223–1238, 2018.
Donkor, A. D., et al. Carbon nanotubes inhibit the hemolytic activity of the pore-forming toxin pyolysin. Nano Res. 2009. https://doi.org/10.1007/s12274-009-9049-0.
Dryden, M., et al. Reactive oxygen therapy: a novel therapy in soft tissue infection. Curr. Opin. Infect. Dis. 30:143–149, 2017.
Engelmann, B. Calcium homeostasis of human erythrocytes and its pathophysiological implications. Klin. Wochenschr. 69:137–142, 1991.
Engelmann, B., and J. Duhm. Intracellular calcium content of human erythrocytes: relation to sodium transport systems. J. Membr. Biol. 98:79–87, 1987.
Farmer, V. C. Infrared spectra of minerals in mineralogical, society monograph 4. London: Mineralogical Society, pp. 183–204, 1974.
Feng, J., and E. S. Thian. Applications of nanobioceramics to healthcare technology. Nanotechnol. Rev. 2:679–697, 2013.
Ferru, E., et al. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood 22:5998–6006, 2011.
Griffiths, P. R. Fourier transform infrared spectrometry. Science 222:297–302, 1983.
Gupta, R., and A. Kumar. Bioactive materials for biomedical applications using sol-gel technology. Biomed. Mater. 3:034005, 2008.
Hair, M. L. Hydroxyl groups on silica surface. J. Non. Cryst. Solids 19:299–309, 1975.
Harisa, G. I., et al. Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel. Saudi Pharm. J. 22:223–230, 2014.
Hayyan, M., et al. Superoxide ion: generation and chemical implications. Chem. Rev. 5:3029–3085, 2016.
Hench, L. L. Bioceramics: from concept to clinic. J. Am. Ceram. Soc. 74:1487–1510, 1991.
Hench, L. L., and J. K. West. The sol-gel process. Chem. Rev. 90:33–72, 1990.
Hussain, T., et al. Oxidative stress and inflammation: what polyphenols can do for us? Oxid. Med. Cell. Long. 5:75–82, 2016.
Jiang, L., et al. Oxidative damage and energy metabolism disorder contribute to the hemolytic effect of amorphous silica nanoparticles. Nanoscale Res. Lett. 11:1–12, 2016.
Kaestner, L., et al. Prostaglandin E2 activates channel-mediated calcium entry in human erythrocytes: an indication for a blood clot formation supporting process. Thromb. Haemost. 92:1269–1272, 2004.
Kalinkina, E. V., et al. Sorption of atmospheric carbon dioxide and structural changes of Ca and Mg silicate minerals during grinding I. Diopside. Int. J. Miner. Process. 61:273–288, 2001.
Keselowsky, B. G., D. M. Collard, and A. J. García. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc. Natl. Acad. Sci. USA 102:5953–5957, 2005.
Kettiger, H., et al. Interactions between silica nanoparticles and phospholipid membranes. Biochim. Biophys. Acta Biomembr. 2163–2170:2016, 1858.
Khandan, A., and N. Ozada. Bredigite-Magnetite (Ca7MgSi4O16-Fe3O4) nanoparticles: a study on their magnetic properties. J. Alloys Compd. 726:729–736, 2017.
Kodicek, M., et al. Red blood cells under mechanical stress. Gen. Physiol. Biophys. 9:291–299, 1990.
Koshi, K., et al. Biological and mineralogical studies on serpentine minerals in heat treated state. Ind. Health 7:66–85, 2009.
Kumar, J. P., et al. Synthesis and characterization of diopside particles and their suitability along with chitosan matrix for bone tissue engineering in Vitro and in Vivo. J. Biomed. Nanotechnol. 6:970–981, 2014.
Lambrecht, L. K., et al. The influence of preadsorbed canine von willebrand factor, fibronectin and fibrinogen on ex vivo artificial surface-induced thrombosis. Thromb. Res. 41:99–117, 1986.
Li, H., et al. Silicate bioceramics enhanced vascularization and osteogenesis through stimulating interactions between endothelia cells and bone marrow stromal cells. Biomaterials 35:3803–3818, 2014.
Lin, Y.-C. The influence of nanodiamond on the oxygenation states and micro rheological properties of human red blood cells. J. Biomed. Opt. 2012. https://doi.org/10.1117/1.jbo.17.10.101512.
Liu, Q., et al. A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and β-TCP ceramics. Biomaterials 29:4792–4799, 2008.
Liu, Z. B., et al. Effect of (CaO + MgO)/SiO2 ratio on crystallisation and properties of slag glass–ceramics. Adv. Appl. Ceram. 55:411–418, 2014.
Liu, X., et al. The modulation of stem cell behaviors by functionalized nanoceramic coatings on Ti-based implants. Bioact. Mater. 1:65–76, 2016.
Liverani, L., et al. Incorporation of bioactive glass nanoparticles in electrospun PCL/chitosan fibers by using benign solvents. Bioact. Mater. 3:55–63, 2018.
Ma, N., et al. In vivo evaluation of the subchronic systemic toxicity of akermanite bioceramic for bone regeneration following ISO standard methods. RSC Adv. 5:69–78, 2019.
Manke, A., L. Wang, and Y. Rojanasakul. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed. Res. Int. 280–290:2013, 2013.
Maynard, A. D., et al. Safe handling of nanotechnology. Nature 444:267–269, 2006.
Merciris, P., et al. Deoxygenation of sickle cells stimulates Syk tyrosine kinase and inhibits a membrane tyrosine phosphatase. Blood 98:3121–3127, 2001.
Mohammadi, H., et al. Bioinorganics in bioactive calcium silicate ceramics for bone tissue repair: bioactivity and biological properties. J. Ceram. Sci. Technol. 5:1–12, 2014.
Mukhopadhyay, S., et al. Synthesis and compatibility evaluation of versatile mesoporous silica nanoparticles with red blood cells: an overview. RSC Adv. 2019. https://doi.org/10.1039/c9ra06127d.
Nemmar, A., et al. Interaction of amorphous silica nanoparticles with erythrocytes in vitro: role of oxidative stress. Cell. Physiol. Biochem. 34:255–265, 2014.
Noh, H., and E. A. Vogler. Volumetric interpretation of protein adsorption: competition from mixtures and the Vroman effect. Biomaterials 2007. https://doi.org/10.1016/j.biomaterials.2006.09.006.
Oberdoester, G. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles (vol 113, pg 823, 2005). Environ. Health Perspect. 118:A380, 2010.
Pan, D., et al. The effect of polymeric nanoparticles on biocompatibility of carrier red blood cells. PLoS ONE 2016. https://doi.org/10.1371/journal.pone.0152074.
Paraskevopoulos, K. M., et al. Study of the bioactive behavior of thermally treated modified 58S bioactive glass. Key Eng. Mater. 396:131–134, 2009.
Parisi, L., et al. A glance on the role of fibronectin in controlling cell response at biomaterial interface. Jpn. Dent. Sci. Rev. 56:50–55, 2020.
Park, E. J., and K. Park. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol. Lett. 184:18–25, 2009.
Paul, W., and C. P. Sharma. Nanoceramic matrices: biomedical applications. Am. J. Biochem. Biotechnol. 2:41–48, 2009.
Prabhu, M., et al. Synthesis, characterization and biological response of magnesium-substituted nanobioactive glass particles for biomedical applications. Ceram. Int. 39:1683–1694, 2013.
Progress, S., and N. Approaches. Clinical applications of biomaterials. NIH Consens Statement Online. 4(5):1–19, 1982.
Serra, J., et al. FTIR and XPS studies of bioactive silica based glasses. J. Non. Cryst. Solids 332:20–27, 2003.
Soares, V. O., et al. New sintered wollastonite glass-ceramic for biomedical applications. Ceram. Int. 44:20019–20027, 2018.
Stefanovic, M., et al. Oxygen regulates the band 3: ankyrin bridge in the human erythrocyte membrane. Biochem. J. 449:143–150, 2013.
Summerton, J., et al. The mechanism of hemolysis by silica and its bearing on silicosis. Exp. Mol. Pathol. 26:113–128, 1977.
Theocharidou, A., et al. Odontogenic differentiation and biomineralization potential of dental pulp stem cells inside Mg-based bioceramic scaffolds under low-level laser treatment. Lasers Med. Sci. 32:201–210, 2017.
Vallet-Regí, M., et al. Effect of magnesium content on the in vitro bioactivity of CaO–MgO–SiO2–P2O5 sol–gel glasses. J. Mater. Chem. 9:515–518, 1999.
Wang, F., et al. Oxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cells. Toxicol. Vitr. 23:808–815, 2009.
Wang, H. J., et al. Is there an optimal topographical surface in nanoscale affecting protein adsorption and cell behaviors? J. Nanopart. Res. 2011. https://doi.org/10.1007/s11051-011-0364-5.
Wu, C., and J. Chang. Synthesis and apatite-formation ability of akermanite. Mater. Lett. 58:2415–2417, 2004.
Wu, C., et al. Porous akermanite scaffolds for bone tissue engineering: preparation, characterization, and in vitro studies. J. Biomed. Mater. Res. 78:47–55, 2006.
Xia, L., et al. Akermanite bioceramics promote osteogenesis, angiogenesis and suppress osteoclastogenesis for osteoporotic bone regeneration. Sci. Rep. 6:1–17, 2016.
Yan, J., et al. Dye-doped nanoparticles for bioanalysis. Nano Today 2:44–50, 2007.
Yu, T., A. Malugin, and H. Ghandehari. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 5:5717, 2011.
Zhang, X., P. Han, A. Jaiprakash, C. Wu, and Y. Xiao. A stimulatory effect of Ca3ZrSi2O9 bioceramics on cementogenic/osteogenic differentiation of periodontal ligament cells. J. Mater. Chem. B 2:1415–1423, 2014.
Zhao, Y., et al. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 5:1366–1375, 2011.
Zhou, W., et al. Synthesis and hemolytic activity of magnesium hydroxide nanoparticles. Adv. Mater. Res. 971:228–231, 2014.
Zielonka, J., et al. Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine. Nat. Protoc. 3:8–21, 2008.
The authors would like to thank for their support MSc student Laura De Diego and Ph.D student Cristina D’Avino.
Conflict of Interest
Ioannis Tsamesid is declares that he has no conflicts of interest. Konstantina Kazeli declares that she has no conflicts of interest. Evgenia Lymperaki declares that she has no conflicts of interest. Georgia K. Pouroutzidou declares that she has no conflicts of interest. Ilias M. Oikonomou declares that he has no conflicts of interest. Philomela Komninou declares that she has no conflicts of interest. George Zachariadis declares that he has no conflicts of interest. Karine Reybier declares that she has no conflicts of interest. Antonella Pantaleo declares that she has no conflicts of interest. Eleana Kontonasaki declares that she has no conflicts of interest.
Patients, all adults, provided written, informed consent before entering the study. The study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. Ethical approval to perform the present study was obtained from the Ethical committee of the ASL. 1-Sassari. No animal experiments were performed in this study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Associate Editor William H. Guilford oversaw the review of this article.
About this article
Cite this article
Tsamesidis, I., Kazeli, K., Lymperaki, E. et al. Effect of Sintering Temperature of Bioactive Glass Nanoceramics on the Hemolytic Activity and Oxidative Stress Biomarkers in Erythrocytes. Cel. Mol. Bioeng. 13, 201–218 (2020). https://doi.org/10.1007/s12195-020-00614-3
- Bioactive glass–ceramic nanoparticles
- Red blood cells
- ROS production